Literature DB >> 11385084

BSE and vCJD: what is the future?

A J Beale.   

Abstract

Mesh:

Year:  2001        PMID: 11385084      PMCID: PMC1281449          DOI: 10.1177/014107680109400501

Source DB:  PubMed          Journal:  J R Soc Med        ISSN: 0141-0768            Impact factor:   5.344


× No keyword cloud information.
  7 in total

1.  Tests for BSE evaluated. Bovine spongiform encephalopathy.

Authors:  J Moynagh; H Schimmel
Journal:  Nature       Date:  1999-07-08       Impact factor: 49.962

2.  Screening slaughtered cattle for BSE.

Authors:  J P Deslys; E Comoy; S Hawkins; S Simon; H Schimmel; G Wells; J Grassi; J Moynagh
Journal:  Nature       Date:  2001-01-25       Impact factor: 49.962

3.  Retrospective study of prion-protein accumulation in tonsil and appendix tissues.

Authors:  J W Ironside; D A Hilton; A Ghani; N J Johnston; L Conyers; L M McCardle; D Best
Journal:  Lancet       Date:  2000-05-13       Impact factor: 79.321

4.  Prion immunoreactivity in appendix before clinical onset of variant Creutzfeldt-Jakob disease.

Authors:  D A Hilton; E Fathers; P Edwards; J W Ironside; J Zajicek
Journal:  Lancet       Date:  1998-08-29       Impact factor: 79.321

5.  Pathogenesis of scrapie in mice after intragastric infection.

Authors:  R H Kimberlin; C A Walker
Journal:  Virus Res       Date:  1989-03       Impact factor: 3.303

6.  Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples.

Authors:  A F Hill; R J Butterworth; S Joiner; G Jackson; M N Rossor; D J Thomas; A Frosh; N Tolley; J E Bell; M Spencer; A King; S Al-Sarraj; J W Ironside; P L Lantos; J Collinge
Journal:  Lancet       Date:  1999-01-16       Impact factor: 79.321

7.  Bovine spongiform encephalopathy: epidemiological studies on the origin.

Authors:  J W Wilesmith; J B Ryan; M J Atkinson
Journal:  Vet Rec       Date:  1991-03-02       Impact factor: 2.695

  7 in total
  1 in total

1.  More on BSE/vCJD.

Authors:  A J Beale
Journal:  J R Soc Med       Date:  2001-12       Impact factor: 5.344

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.